Few Discontinuation Symptoms Reported After Stopping Antidepressants
By Elana Gotkine HealthDay Reporter
THURSDAY, July 17, 2025 -- Most individuals do not go through severe withdrawal after discontinuing antidepressants, according to a study published online July 9 in JAMA Psychiatry.
Michail Kalfas, from King's College London, and colleagues conducted a systematic review and meta-analysis to examine the presence of discontinuation symptoms using standardized scales (e.g., Discontinuation-Emergent Signs and Symptoms [DESS]) and the incidence of individual discontinuation symptoms in a review of randomized clinical trials involving individuals who stop taking antidepressants. Fifty studies with 17,828 individuals were reviewed, and 49 studies were included in meta-analyses.
The researchers found that the DESS meta-analysis indicated increased discontinuation symptoms at one week in participants stopping antidepressants versus those taking placebo or continuing antidepressants (standardized mean difference, 0.31), with an effect size equivalent to one more symptom on the DESS. Increased odds of dizziness, nausea, vertigo, and nervousness were seen with discontinuation of antidepressants compared with placebo discontinuation. The most prevalent symptom of discontinuation was dizziness (risk difference, 6.24 percent). Despite being measured in people with major depressive disorder, discontinuation was not associated with depression symptoms.
"Despite previous concern about stopping antidepressants, our work finds that most people do not experience severe withdrawal, in terms of additional symptoms. Importantly, depression relapse was not linked to antidepressant withdrawal in these studies," senior author Sameer Jauhar, Ph.D., also from King’s College London, said in a statement.
Several authors disclosed ties to relevant organizations.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2025
Read this next
Oseltamivir for Flu Tied to Reduced Risk for Serious Neuropsychiatric Events in Children
THURSDAY, Aug. 7, 2025 -- Oseltamivir treatment during influenza episodes is associated with a reduced risk for serious neuropsychiatric events among children and teens, according...
Similar Impact on Mental Health Seen for Exposure to Physical, Verbal Abuse in Childhood
WEDNESDAY, Aug. 6, 2025 -- Exposure to childhood physical or verbal abuse is similarly associated with lower mental well-being during adulthood, according to a study published...
Mental Illness Increased During, After Pregnancy for Gestational Carriers
MONDAY, Aug. 4, 2025 -- Gestational carriers seem to be more likely to be diagnosed with mental illness during and after pregnancy than those with unassisted pregnancies or...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.